Barnes Wealth Management Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Barnes Wealth Management Group's BMY Position: Q3 2026 in Review
Barnes Wealth Management Group reduced its Bristol-Myers Squibb (BMY) stake by 0.1% in Q3 2026, selling an estimated $253 and leaving 3,927 shares worth $245K. The position accounts for 0.11% of the portfolio, ranked #169.
Barnes Wealth Management Group first reported a position in BMY in Q4 2024 and has held it in 6 quarters since. The position peaked at $294K in Q1 2025. 2,253 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Barnes Wealth Management Group held 3,927 shares of Bristol-Myers Squibb worth $245K as of Q3 2026.
- Barnes Wealth Management Group sold 4 Bristol-Myers Squibb shares in Q3 2026, an estimated $253.
- Bristol-Myers Squibb made up 0.11% of Barnes Wealth Management Group's portfolio in Q3 2026, its #169 holding.
- Barnes Wealth Management Group first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 6 quarters since.
- Barnes Wealth Management Group's Bristol-Myers Squibb position peaked at $294K in Q1 2025.
- 2,253 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Barnes Wealth Management Group's 13F filing for Q3 2026, filed 9 Nov 2026.